+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celldex Therapeutics, Inc.  - logo

Celldex Therapeutics is a biopharmaceutical company that develops, manufactures, and commercializes novel therapeutics for human health care. The company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines. The company's lead drug candidates are Rintega, Glembatumumab vedotin, Varlilumab and others. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex. It is now headquartered in Hampton, New Jersey.

From
From
From
From
From
From
From
From
Brain Hemorrhage - Pipeline Insight, 2020 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Global Cancer Vaccine Market & Clinical Trial Insight - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trial Insight

  • Clinical Trials
  • September 2015
  • 750 Pages
From
From
From
From
Thyroid Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • March 2020
  • 885 Pages
From
Monoclonal Antibodies (MAbS) Global Market Report 2020 - Product Thumbnail Image

Monoclonal Antibodies (MAbS) Global Market Report 2020

  • Report
  • December 2019
  • 200 Pages
From
Thyroid Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Loading Indicator
adroll